Eli Lilly (LLY) Dividends payables (2009 - 2025)

Eli Lilly (LLY) has reported Dividends payables for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2025.

• Dividends payables for Q2 2025 came in at $1.3 billion, up 14.93% year-over-year; the trailing twelve-month figure through Jun 2025 was $1.3 billion (up 14.93% YoY), and the FY2024 annual result was $1.3 billion, up 15.15% from the prior year.
• Dividends payables was $1.3 billion for Q2 2025 at Eli Lilly, roughly flat from $1.3 billion in the prior quarter.
• Over five years, Dividends payables peaked at $1.3 billion in Q4 2024 and troughed at $770.8 million in Q2 2021.
• Average Dividends payables over 5 years is $1.1 billion, with a median of $1.0 billion recorded in 2022.
• Year-over-year, Dividends payables climbed 14.45% in 2022 and increased 15.19% in 2023.
• Over 5 years, Dividends payables stood at $885.5 million in 2021, then increased by 14.87% to $1.0 billion in 2022, then climbed by 14.94% to $1.2 billion in 2023, then advanced by 15.15% to $1.3 billion in 2024, then decreased by 0.08% to $1.3 billion in 2025.
• Per Business Quant data, the three most recent Dividends payables figures were $1.3 billion in Q2 2025, $1.3 billion in Q4 2024, and $1.2 billion in Q2 2024.